What is Zacks Small Cap’s Forecast for MGRM Q1 Earnings?

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) – Equities researchers at Zacks Small Cap issued their Q1 2025 EPS estimates for Monogram Orthopaedics in a report released on Thursday, March 13th. Zacks Small Cap analyst T. Kerr anticipates that the company will post earnings of ($0.10) per share for the quarter. The consensus estimate for Monogram Orthopaedics’ current full-year earnings is ($0.49) per share. Zacks Small Cap also issued estimates for Monogram Orthopaedics’ Q2 2025 earnings at ($0.10) EPS, Q4 2025 earnings at ($0.13) EPS, FY2025 earnings at ($0.44) EPS and FY2026 earnings at ($0.16) EPS.

MGRM has been the subject of several other research reports. Roth Mkm boosted their price objective on shares of Monogram Orthopaedics from $4.00 to $5.40 and gave the stock a “buy” rating in a research report on Tuesday. Roth Capital set a $5.40 target price on shares of Monogram Orthopaedics in a research report on Tuesday.

Monogram Orthopaedics Price Performance

MGRM stock opened at $3.43 on Monday. The company has a 50 day moving average price of $2.58 and a 200 day moving average price of $2.50. Monogram Orthopaedics has a fifty-two week low of $1.53 and a fifty-two week high of $4.90. The stock has a market capitalization of $121.04 million, a PE ratio of -7.30 and a beta of 1.66.

Monogram Orthopaedics (NASDAQ:MGRM) last posted its earnings results on Wednesday, March 12th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.03.

Hedge Funds Weigh In On Monogram Orthopaedics

Several institutional investors and hedge funds have recently made changes to their positions in the company. Commonwealth Equity Services LLC grew its holdings in shares of Monogram Orthopaedics by 21.5% in the 4th quarter. Commonwealth Equity Services LLC now owns 41,628 shares of the company’s stock valued at $99,000 after buying an additional 7,366 shares during the period. Wells Fargo & Company MN grew its holdings in shares of Monogram Orthopaedics by 286.6% in the 4th quarter. Wells Fargo & Company MN now owns 11,597 shares of the company’s stock valued at $27,000 after buying an additional 8,597 shares during the period. Jane Street Group LLC acquired a new position in Monogram Orthopaedics in the 4th quarter worth $25,000. Barclays PLC acquired a new position in Monogram Orthopaedics in the 3rd quarter worth $29,000. Finally, Orion Portfolio Solutions LLC acquired a new position in Monogram Orthopaedics in the 4th quarter worth $31,000. Institutional investors and hedge funds own 0.45% of the company’s stock.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.